Why pharmacogenomics? Why now?
Nat Biotechnol
.
1998 Jun;16(6):492-3.
doi: 10.1038/nbt0698-492.
Authors
D Housman
1
,
F D Ledley
Affiliation
1
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, USA.
PMID:
9624664
DOI:
10.1038/nbt0698-492
No abstract available
Publication types
Review
MeSH terms
Genetic Variation*
Genome, Human*
Humans
Pharmacogenetics / trends*